Clinical Trials Browser

Interventional × Peptides × Tumor-Agnostic × Clear all

NCT02721043 2021-01-11

Safety and Immunogenicity of Personalized Genomic Vaccine to Treat Malignancies

Phase 1 Completed

Neoplasms